Probing the Origins of Increased Activity of the E22Q “Dutch” Mutant Alzheimer's β-Amyloid Peptide  by Massi, Francesca & Straub, John E.
Probing the Origins of Increased Activity of the E22Q “Dutch” Mutant
Alzheimer’s -Amyloid Peptide
Francesca Massi and John E. Straub
Department of Chemistry, Boston University, Boston, Massachusetts 02215 USA
ABSTRACT The amyloid peptide congener A(10–35)-NH2 is simulated in an aqueous environment in both the wild type
(WT) and E22Q “Dutch” mutant forms. The origin of the noted increase in deposition activity resulting from the Dutch mutation
is investigated. Multiple nanosecond time scale molecular dynamics trajectories were performed and analyzed using a variety
of measures of the peptide’s average structure, hydration, conformational fluctuations, and dynamics. The results of the study
support the conclusions that 1) the E22Q mutant and WT peptide are both stable in “collapsed coil” conformations consistent
with the WT structure of Zhang et al. (2000, J. Struct. Biol. 130:130–141); 2) the E22Q peptide is more flexible in solution,
supporting early claims that its equilibrium structural fluctuations are larger than those of the WT peptide; and 3) the local
E22Q mutation leads to a change in the first solvation layer in the region of the peptide’s “hydrophobic patch,” resulting in
a more hydrophobic solvation of the mutant peptide. The simulation results support the view that the noted increase in activity
due to the Dutch mutation results from an enhancement of the desolvation process that is an essential step in the aggregation
of the peptide.
BACKGROUND
The -amyloid hypothesis, championed by Selkoe (1994,
1997) and others, is the most studied and best developed
theory for one of the underlying causes of Alzheimer’s
disease. A growing number of experimental studies of the
structure of solvated peptide and fibrils, and the activity of
the peptide in the process of fibril growth, are beginning to
define the fundamentals of a mechanism of amyloid fibril-
logenesis and fibril elongation.
A number of proposals (Zagorski and Barrow, 1992;
Talafous et al., 1994) have been put forward regarding the
activity of the A-peptide and its sequence dependence. An
early proposal was based on the paradigm of an 3
transition, where the peptide, which was assumed to be
predominately -helical, underwent a solution phase con-
formational transition to an activated form of the peptide.
This activated form was characterized by backbone geom-
etry that was largely -sheet or strand and consistent with
the predominately -form of the fibril aggregates.
That initial proposal is still seriously considered by some
(Marcinowski et al., 1998; Shao et al., 1998). However,
there is a growing body of evidence that argues against it.
Most notably, a solution phase NMR structure of a A(10–
35)-peptide congener has been determined by Lee and co-
workers (Zhang et al., 2000). The structure, which was
described as a “collapsed coil” (cc) and characterized by a
central hydrophobic cluster and a robust adjacent turn re-
gion, clearly demonstrates that the peptide lacks -helical
character as a monomer in aqueous solution. Subsequent
multiple nanosecond molecular dynamics calculations of
the fully solvated A(10–35)-peptide congener found that
the peptide exhibited stable fluctuations about the charac-
teristic collapsed coil structure (Massi et al., 2001). Com-
parison with experimental measures of structure, fluctua-
tions, and dynamics derived from NMR and quasielastic
light scattering experiments, including NMR amide bond
order parameters, peptide diffusion constants, and the radius
of gyration, indicated that the simulation model captured
not only the dominant features of the stable peptide fold but
the range of fluctuations in the less structured C- and
N-terminal regions of the peptide.
Although these experimental and computational data ar-
gue against the significance of an 3 transition in the
solution phase monomeric peptide, it is possible that a
cc3 transition could be essential to the peptide’s activity.
Experimental studies of A-peptide fibril elongation by
Teplow and coworkers (Kusumoto et al., 1998) and depo-
sition by Maggio and coworkers (Esler et al., 1996, 2000b),
have recently been analyzed in terms of an “energy land-
scape mechanism” for A-peptide fibril elongation by
Massi and Straub (2001). Our proposed mechanism consists
of two principal channels: 1) a prion-like channel where the
monomeric peptide undergoes a fluctuation to an activated
-peptide state followed by fast addition to the existing
-fibril, and 2) a two-step mechanism of nonspecific ad-
sorption of the collapsed coil peptide on the fibril surface
followed by reorganization to well-formed -fibril. As such,
it unifies the proposed mechanisms of a crucial cc3
conformational transition in the monomeric peptide with the
adsorption/reorganization pathway first proposed by
Teplow and coworkers (Kusumoto et al., 1998) and ex-
panded on by Maggio and coworkers (Esler et al., 2000b).
Experimental evidence suggests that for the activity of the
wild type A(10–35)-peptide, the second channel—a two-
step process of adsorption and reorganization—may pre-
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dominate. However, the proposed mechanism of Massi and
Straub is inclusive of both pathways, and the associated
kinetics gives an excellent fit with experimental data for
rates of deposition and fibril elongation (Massi and Straub,
2001).
An important goal of research on A-peptide aggregation
is to understand the role of sequence in the peptide’s activ-
ity, where it is known that sequence can play a crucial role.
Two particular naturally occurring mutant forms of the wild
type A-peptide, the E22Q “Dutch” mutant and the E22K
“Italian” mutant, have been the focus of structural and
activity studies (Miravalle et al., 2000; Melchor et al.,
2000). To date, it is well understood that the E22Q mutant
shows enhanced activity (as measured by the rate of depo-
sition or fibril elongation) relative to the wild type (WT)
peptide for both the 1–42 A-peptide and the A(10–35)-
peptide congener (Miravalle et al., 2000; Esler et al.,
2000a). The exact nature of the structure of the monomeric
E22Q mutant peptide in aqueous solution however, remains
controversial.
There is, to date, no NMR-derived structure of the E22Q
mutant peptide analogous to the structure of the WT
A(10–35)-peptide congener. However, NMR measure-
ments of H proton chemical shifts for the WT and E22Q
mutant A(10–35)-peptides are consistent with a structure
of the E22Q mutant that is indistinguishable from the
known cc structure of the WT peptide (Zhang, 1999).
In a related study, the rate of peptide deposition was
measured for the A(10–35)-peptide congener (Esler et al.,
2000a). A simple and approximate Arrhenius rate theory
model was used to derive the activation enthalpy and en-
tropy for the deposition rate constants of the WT and the
E22Q mutant forms of the peptide (where the mutant pep-
tide was found to deposit at a rate 215% faster than the WT
peptide). The authors attributed the difference between the
activity of the WT and E22Q peptides to a difference in the
entropy of activation, implying that the mutant peptide was
characterized by a looser, entropically stabilized transition
state structure relative to that of the WT peptide (Esler et al.,
2000a).
In a study of Austen and coworkers (Sian et al., 2000), it
was found that A(1–40)E22Q peptide formed oligomers
and fibrils more rapidly than the WT peptide. Using circular
dichroism (CD) spectroscopy, they observed that the rate of
change from mainly random coil to -sheet was more than
one order of magnitude higher in the E22Q than in the WT.
The rates of conversion from random coil to -sheet in the
WT and E22Q mutant peptides, derived from CD measure-
ments, were an order of magnitude lower than the rate of
formation of low-molecular-mass oligomers (detected by
ELISA and gel filtration). The study concluded that the
A-peptide aggregates into an irregular structure and sub-
sequently undergoes a slower conformational transition into
aggregates of -sheets. Such a pathway is consistent with
the second channel of the mechanism of Massi and Straub
(2001).
However, there is also evidence that the E22Q peptide
has a propensity for the formation of -structure in solution.
One study, performed by Selkoe and coworkers (Watson et
al., 1997), explored the binding of heparin to solutions of
WT and E22Q mutant A-peptide. Heparin binds to fibrillar
(and not to nonfibrillar) A-peptide. However, the under-
lying cause of the specificity of binding is not understood.
Peptide was neutralized in a 1-mM aqueous solution and
incubated for 48 h at 4°C and then lyophilized. It was found
that the E22Q mutant peptide assumed conformations to
which heparin would bind more readily than did the WT
peptide. In fact, the affinity of heparin binding to the E22Q
mutant peptide was similar to the affinity for binding of
heparin to preformed -fibrils. The conclusion was that the
water-aggregated E22Q mutant peptide adopted structures
similar to those found in fibrils with substantial -pleated
sheet conformation (Watson et al., 1997).
An experimental study by Miravalle et al. (2000) using
CD and Fourier transform infrared spectroscopy measure-
ments found that, although the WT and the E22K peptide
were largely of the random coil conformation in solution,
the E22Q peptide assumed a -sheet conformation. The
study explored the time dependence of peptide aggregation
by CD and showed that, for their sample preparations, the
WT, E22K, and E22Q peptide converted to -structure over
a period of hours. However, although CD spectra of the WT
and E22K peptide samples indicated that, at the earliest
times, the peptide was in a random coil conformation, the
E22Q peptide sample showed the clear signs of -structure.
This observation could be used to support the hypothesis
that the E22Q mutant peptide may form an “activated”
-form of the monomeric peptide more readily than the WT
peptide (Miravalle et al., 2000). Such a mechanism would
be consistent with the first channel of the mechanism of
Massi and Straub. However, the results in the case of the
E22Q mutant peptide could also be due to the presence of
peptide aggregates from the earliest stages of the CD mea-
surements.
A possible explanation for these discrepancies lies in the
sample preparation. The NMR studies of Lee and coworkers
(Zhang et al., 2000), which included WT and E22Q peptides
samples at 250 M and higher concentration, was based on
a careful preparation of a stable sample of dissolved, mo-
nomeric peptide. As has been noted, the careful preparation
of samples, through extensive ultracentrifugation to remove
“seeds” that might nucleate aggregates, can result in sam-
ples of monomeric peptide that are stable for months at a
time. Less rigorous sample-preparation protocols may result
in artifacts due to incomplete dissolution.
In this computational study, we explore the hypothesis
that the E22Q mutation leads to a monomeric peptide that
has a higher propensity, relative to the WT peptide, for
undergoing conformational fluctuations to an activated
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-form of the peptide. Multiple nanosecond time scale
molecular dynamics trajectories were performed and ana-
lyzed using a variety of measures of the peptide’s average
structure, hydration, conformational fluctuations, and dy-
namics. The results of the study support the following
conclusions. 1) The E22Q mutant and WT peptide are both
stable in cc conformations consistent with the WT structure
of Lee and coworkers (Zhang et al., 2000). 2) The E22Q
peptide is more flexible in solution, consistent with early
claims that its equilibrium structural fluctuations were
larger than those of the WT peptide. 3) The local E22Q
mutation leads to a change in peptide hydration and the
structure of the first solvation layer in the region of the
peptide’s “hydrophobic patch.” Our concluding discussion
includes speculation on how these observations lead to a
consistent picture of the observed increased activity of the
E22Q mutant relative to the WT peptide.
METHODS
The starting point for our simulations of the wild type (10–35)-NH2
peptide and the E22Q mutant peptide was the WT nuclear magnetic
resonance (NMR) solution structure of Lee and coworkers (Zhang et al.,
2000) derived from distance geometry calculations using NMR-derived
NOE restraints. The initial structure of the E22Q mutant was derived from
the WT structure by mutating residue 22. The E22Q Dutch mutant peptide
congener is depicted in Fig. 1. The colored regions are Tyr10-Glu11-Val12-
His13-His14-Gln15-Lys16 (blue/gray), Leu17-Val18-Phe19-Phe20-Ala21 (red),
Glu22/Gln22 (green), Asp23 (blue/gray), Val24-Gly25-Ser26-Asn27 (yellow),
Lys28-Gly29-Ala30-Ile31-Ile32-Gly33-Leu34-Met35 (blue/gray). The domi-
nant structural motifs in the peptide are the hydrophobic cluster LVFFA
17–21 segment (red), the turn 24–27 VGSN segment (yellow), and the
glutamine residue Q22 that is positioned at the interface between the
hydrophobic cluster and turn regions.
For the fully solvated WT and mutant peptide, four independent 1-ns
trajectories were simulated. Each trajectory originated from one of a set of
four initial peptide structures that were chosen from two families of
conformers characterized by variations in their C-terminal regions. The
initial structures resulted from the work of Lee and coworkers who used a
combination of distance geometry refinement and molecular dynamics
annealing/minimization procedures using experimentally derived NOE re-
straints. Further details of the refinement have been published elsewhere
(Lee et al., 1995; Zhang, 1999; Zhang et al., 2000; Massi et al., 2001).
In the remainder of this section, we describe the simulation model used
in our study. The standard methods used to characterize the peptide’s
structure and fluctuations include amide bond vector order parameters,
residue fluctuation matrix, rates of self-diffusion, measures of backbone
fluctuation, and ordering of water molecules in the first solvation shell. A
description of many elements of this analysis protocol has been previously
presented (Massi et al., 2001).
Simulation model of the WT peptide congener in
aqueous solution
For the simulations of the wild-type and mutant peptides, the solute was
centered in a rhombic dodecahedron cell that was carved from a cubic box
of 50 Å on a side and then filled with 2113 water molecules. Because
periodic boundary conditions were applied to avoid edge effects, this
corresponds to a 31-mM concentration of peptide. The energetics of the A
peptide in water was simulated using the version 22 potential energy
function of the CHARMM program (Mackerell et al., 1998). The potential
energy cut-off distance for the nonbonded interactions was 12.0 Å. Ewald
summation was used to evaluate the electrostatic interactions. SHAKE was
used to constrain bonds involving hydrogen atoms to their equilibrium
values. A time step of integration of 2 fs was used in the Verlet algorithm
in the CHARMM program (Brooks et al., 1983). No NMR restraints were
used throughout the simulations. After the equilibration period of 200 ps,
a production run of 1 ns constant energy molecular dynamics was com-
pleted with an average temperature of 300 K. Every 200 fs, coordinates and
energetic data were collected. The core regions of the peptide, including
the LVFFA and VGSN substructures, were largely similar in the four
starting configurations. However, outside of that core structure, there was
significant disorder in the N- and C-terminal regions of the peptide due to
the small number of experimentally derived restraints in those regions that
were used in the structural refinement.
Measures of peptide dynamics
and reorganization
We use a number of useful measures of the peptide dynamics, including the
rate of translational diffusion of the peptide and variations in the compact-
ness of the peptide as measured by the radius of gyration and peptide
end-to-end distance.
FIGURE 1 The E22Q mutant form of the congener amyloid (10–35)-
NH2 peptide is depicted. From the N-terminus, the groups are Tyr10-Glu11-
Val12-His13-His14-Gln15-Lys16 (blue/gray), Leu17-Val18-Phe19-Phe20-Ala21
(red), Glu22 (green), Asp23 (blue/gray), Val24-Gly25-Ser26-Asn27 (yellow),
Lys28-Gly29-Ala30-Ile32-Gly33-Leu34-Met35 (blue/gray).
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Self-diffusion constant for the peptide
The mean-square displacement of the center-of-mass of the peptide was
computed as a function of time. The diffusion constant of the peptide
monomer was estimated using the Einstein relation
rCOMt2 6Dt, (1)
where rCOM(t) is the center of mass coordinate. Eq. 1 is expected to hold
in the limit of long times. The mean square displacement was computed
over the length of the trajectory and the slope was measured to determine
the diffusion constant.
Radius of gyration
The radius of gyration for the peptide was computed using all of the
peptide atoms in the standard formula (Berne and Pecora, 1976)
rg2 
k
N
mkrk rCOM2
k
N
mk, (2)
where rk is the position of the kth atom in the peptide, and mk is its mass.
Summed averages were generated over each full trajectory to determine the
ensemble averaged rg2.
Peptide end-to-end distance
The peptide’s end-to-end distance was defined by the distance separating
the first N atom of the N-terminal Tyr10 and the second end N atom
attached to the carbonyl carbon atom of the C-terminal Met35. That
calculation is equivalent to the definition
re 
i
li, (3)
where li is the vector connecting the consecutive N atoms along the
backbone between the N- and C-termini. The ensemble averaged value re2
was computed by averaging over the molecular dynamics trajectories.
Large changes in re indicate significant reorganization in the peptide’s
global structure.
Characterizing the peptide structure in solution
For each saved configuration, the peptide was analyzed for hydrogen
bonding groups for all possible donors and acceptors. The hydrogen
bonding frequency was averaged over the full simulation by dividing the
number of snapshots (instantaneous configurations) showing hydrogen
bonds by the total number of snapshots. The following definition of the
hydrogen bond was used: the donor and acceptor atoms were required to be
at a distance shorter than or equal to 2.5 Å and the angle between the donor
and acceptor diatomic groups is in the range 113–180° (Simmerling et al.,
1995).
The atomic exposed surface area was computed by the method de-
scribed by Wesson and Eisenberg (1992) and originally developed by Lee
and Richards (1971). The solvent-exposed surface area of each atom was
defined as the area exposed to contact by a water probe of diameter 2.8 Å.
The upper bound on the solvent-exposed surface area was taken to be the
surface area for the peptide in a modeled extended configuration. Each
trajectory was analyzed by computing the total solvent-exposed surface
area of the whole peptide (as well as a calculation restricted to those atoms
composing the LVFFA region).
Lipari–Szabo NMR order parameters
We follow the standard “model free” analysis of Lipari and Szabo
(1982a,b). The motion of the peptide can be described by a correlation
function C(t) for the orientation of a peptide backbone amide bond vector.
Assuming that the internal motions are uncorrelated with the overall
molecular tumbling, C(t) can be factored into two contributions—one for
the internal motions and another for the overall molecular rotation as
Ct CtumbtCintt 15 e
t/0Cintt. (4)
Using Y2m(, 	), the second-order spherical harmonics, with  and 	
specifying the orientation of the internuclear NH amide bond vector in the
molecule-fixed coordinate frame, the internal motions of the peptide can be
characterized by two parameters: a generalized order parameter, S,
S2 lim
t3
Cintt
4

5 r
61 
m	2
2 Y2m, 	r3 
2
,
(5)
and an effective correlation time, int.
S is a measure of the degree of freedom of the motion of the intermo-
lecular amide bond vector; S is unity if the motion is completely restricted;
S is zero for isotropic motion. To separate the overall molecular rotation
from the internal motion, every coordinate frame of the 1-ns trajectory was
translated and rotated until the root mean square (RMS) displacement with
respect to a reference configuration (t	 0) was minimized (Philippopoulos
and Lim, 1994). The values of the generalized order parameter, S2, for the
NH amide bond vector are presented in Table 1.
TABLE 1 The computed and experimentally derived values
of the S2 order parameter
S2
Amino Acid Simulation (WT) Simulation (Dutch) Experiment (WT)
Tyr10 0.21 0.01
Glu11 0.50 0.32
Val12 0.56 0.45
His13 0.51 0.56
His14 0.45 0.43
Gln15 0.66 0.56
Lys16 0.74 0.71
Leu17 0.66 0.68
Val18 0.65 0.74 0.68  0.05
Phe19 0.72 0.74 0.75  0.05
Phe20 0.69 0.69 0.79  0.05
Ala21 0.51 0.47
Glu22 0.66 0.52
Asp23 0.51 0.48
Val24 0.55 0.58 0.75  0.05
Gly25 0.66 0.55 0.76  0.05
Ser26 0.55 0.45
Asn27 0.51 0.57
Lys28 0.62 0.68
Gly29 0.55 0.70 0.64  0.06
Ala30 0.45 0.64
Ile31 0.40 0.51
Ile32 0.50 0.58
Gly33 0.43 0.45 0.54  0.06
Leu34 0.36 0.44
Met35 0.41 0.43
700 Massi and Straub
Biophysical Journal 81(2) 697–709
Cross correlation matrix analysis of
peptide fluctuations
To develop a measure of the correlation in the fluctuations of the peptide
residues, the cross correlation matrix of cartesian coordinate fluctuations
was analyzed. The elements of the matrix are defined (Haliloglu and Bahar,
1998)
Mij RiRj/Ri2Rj21/2, (6)
where the angle brackets indicate an average over the length of the
simulation. The correlation matrix is useful in recognizing groups of atoms
that move with high correlation. This may be the case for clusters of atoms
or residues as well as segments of secondary structure such as -helices
and -sheets.
Peptide hydration analysis of the first
solvation shell
Cheng and Rossky (1999) have proposed a novel measure of the hydration
structure near a solute interface. It is known that water near the convex
surface of a small hydrophobic solute tends to form a clathrate cage
structure (Fig. 2). Such a solvation shell allows for water–water hydrogen
bonding and reduces water–water hydrogen bonding enthalpy at the cost of
decreasing the water’s configurational entropy. Near a charged solute, the
water molecules tend to assume an inverted orientation (Fig. 2) with an
O–H bond or lone pair directed inward toward the solute.
However, when the hydrophobic solute–water interface is less convex,
or even planar or concave, the water may no longer assume the classic
clathrate cage structure, due to topological constraints. Cheng and Rossky
have developed a number of measures of the degree of clathrate or inverted
character in water orientation and applied those measures to examine the
hydration shells of a number of proteins, including mellitin and the active
site of -chymotrypsin (Cheng and Rossky, 1999; Cheng et al., 1999;
Carey et al., 2000). One of their measures is depicted in Fig. 2. The
parameter fin is an order parameter for the degree of clathrate-like or
inverted water structure. Their analysis has shown that water structure near
hydrophobic protein surfaces is sensitive to the topological constraints. In
this work, we have used this measure to analyze the hydration structure
over the full surface of the A-peptide with a particular interest in the
hydration structure in the region of the anomalously large hydrophobic
patch centered about the LVFFA cluster. To further investigate the ener-
getics of the hydration shells of the WT and mutant peptides, we also
computed the average binding energy, Eb, of proximal water molecules for
every residue of the peptide. The binding energy Eb was decomposed into
contributions from the interaction of the water in the first solvation shell
with all the other water molecules in the system, Ew, and with the pep-
tide, Ep.
FIGURE 2 A schematic diagram describing the relation of the order
parameter for the peptide’s first hydration shell, after Fig. 2 of Cheng et al.
(1999).
FIGURE 3 A collage composed of snapshot configurations taken every
100 ps along the four 1-ns trajectories for the WT or E22Q mutant peptide.
The peptide backbone structures are overlapped to best fit the central core
region of the peptide.
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RESULTS
Peptide solution structure and fluctuations
The average structure and conformational fluctuations of
the solvated WT and E22Q mutant peptides were deter-
mined from an analysis of the independent trajectories. The
results were analyzed in terms of the average structure, the
distributions of peptide end-to-end distance and radius of
gyration, the fluctuations in the atomic positions and back-
bone torsional angles, and the computed amide bond vector
orientational Lipari–Szabo order parameters.
WT and E22Q mutant peptide solution structures
are similar
Overlapping instantaneous structures taken from the end-
points of the independent nanosecond trajectories are shown
in Fig. 3. The core regions of the peptide, including the
LVFFA central hydrophobic cluster and VGSN turn region,
are largely conserved over the full length of the dynamics of
the WT and E22Q mutant peptide. In both the WT and
E22Q mutant peptides, the N-terminal region tends to be
significantly more disordered than the C-terminal region.
Overall, the average structures of the WT and E22Q mutant
peptides are similar.
It has been reported that the monomeric E22Q mutant
peptide assumes a  conformation in solution. However, our
results indicate that the monomeric E22Q mutant peptide
maintains a structure quite similar to the WT peptide over
the length of our dynamical simulations.
Diffusion constants for WT and E22Q peptides
are comparable
The translational self-diffusion constant for the E22Q mu-
tant peptide was computed using the Einstein relation for
FIGURE 4 The end-to-end distance for the peptide computed for the
simulation runs of both the WT and E22Q mutant peptides.
FIGURE 5 The radius of gyration of the peptide computed for the
simulation runs of both the WT and E22Q mutant peptides.
FIGURE 6 Plot of the amide bond vector order parameter S2 for the
simulation runs of both the WT and E22Q mutant peptides.
FIGURE 7 The averaged RMS atomic coordinate deviation from the
average peptide structure computed over each of the simulation runs of
both the WT and E22Q mutant peptides.
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the mean-square displacement of the peptide’s center of
mass. Values of the diffusion constant were derived from
fits to the asymptotic linear regions of the mean-square
displacement. The average diffusion constant is approx-
imately D 	 (1.5 
 0.4)  106 cm2/s. This is the same
value, within the error, that was found from the simula-
tion of the WT peptide, whose diffusion constant was
estimated to be equal to (1.4 
 0.4)  106 cm2/s (Massi
et al., 2001).
E22Q peptide end-to-end distance biased to
short distances
The distributions of end-to-end distance, binned over the
independent trajectories of the WT and E22Q mutant
peptides, are depicted in Fig. 4. There is a significant
difference in the distributions with the end-to-end dis-
tance in the E22Q mutant being significantly smaller, on
average, and broader, in fluctuation, than the distribution
for the WT peptide.
E22Q peptide more open than WT
The distributions of the radius of gyration for the WT and
E22Q mutant peptides are shown in Fig. 5. On average, the
E22Q mutant peptide appears to be somewhat more ex-
panded than the WT peptide. This is consistent with the
FIGURE 8 The averaged RMS atomic coordinate deviation from the
average peptide structure computed for the  and 	 backbone torsional
angles for the simulation runs of both the WT and E22Q mutant peptides.
FIGURE 9 Plot of the hydrogen-bonding probabilities averaged for the
simulations of the WT and E22Q mutant peptides. Hydrogen bond accep-
tors are noted along the x-axis and donors are indicated along the y-axis.
The acceptors indicated with single letters are side chain groups; those that
follow are backbone carbonyl oxygen atoms. Similarly, the donors indi-
cated with single letters are side chain groups; the remaining donors are
backbone amide hydrogen atoms. Below each histogram is found a plot
depicting the connectivity of the most prominent hydrogen bonds. Con-
nections are shown between the LVFFA and VGSN regions (dashed),
between side chain and backbone groups (dotted), and between backbone
and backbone groups (solid). Hydrogen bond connections found in com-
mon between the WT and E22Q mutant peptides are also noted (dot-
dashed).
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E22Q mutant peptide having a larger solvent-exposed sur-
face area than is found for the WT peptide (see below).
Simulated NMR order parameters in WT and E22Q
are similar
The NH amide bond vector Lipari–Szabo order parameters
are plotted in Fig. 6. For the most part, the relative variation
in the S2 values, over the length of the peptide, is similar for
each peptide. The N-terminal region is significantly more
disordered than the C-terminal region in both the WT and
E22Q mutant peptides. The LVFFA region has large amide
bond vector orientational order in both peptides. There are,
however, two distinct differences between the S2 values of
the WT and E22Q mutant peptides. The most notable dif-
ference is the significantly smaller S2 value of residue 22 for
the E22Q mutant peptide, indicating greater orientational
fluctuation of the NH amide bond in the mutant peptide
dynamics relative to the WT peptide. Also, in the 28–32
region of the peptide, the mutant peptide shows signifi-
cantly greater correlation than in the corresponding region
of the WT peptide.
There is a significantly greater average fluctuation of
the atoms of residue 22 in the dynamics of the E22Q
mutant peptide relative to the WT peptide (see Fig. 7).
Large-scale motion of the N- and C-terminal regions is
common to both peptides in all simulations. The central
core regions of the peptide tend to show RMS fluctua-
tions on the order of 2 Å. However, the RMS fluctuations
of the Q22 residue in the E22Q mutant peptide appear to
be on the order of 3 Å and comparable to the RMS
fluctuations of atoms in the C-terminal region of the
peptide. Note the large fluctuations in the loop region
centered about residue Glu22 in the dynamics of the
mutant peptide. The larger fluctuations in Glu22 are
flanked by smaller fluctuations throughout the LVFFA
(17–21) central hydrophobic cluster and particularly in
the VGSN (24–27) turn region. The results are consistent
with NMR measurements of the proton chemical shifts
that demonstrate that these regions tend to be particularly
well structured in aqueous solution and reasonably insen-
sitive to changes in temperature in the range 5–35°C
(Zhang, 1999).
The magnitude of fluctuations in the 	– angles of the
peptide’s backbone are displayed in Fig. 8. The overall
magnitude of fluctuations in the peptide’s backbone is
similar in the WT and E22Q mutant peptides. A differ-
ence can be seen in the VGSN region where the fluctu-
ations appear to be significantly larger in the E22Q
mutant peptide. Those larger fluctuations may be corre-
lated with a somewhat diminished values of the S2 order
parameter in that region for the E22Q mutant peptide (see
Fig. 6).
H-bonds between LVFFA and VGSN region
disrupted in E22Q peptide
Although there are significant fluctuations in the structure
of the WT and E22Q mutant peptide over the course of the
nanosecond dynamical trajectories, the peptide has been
shown to have a well-defined average structure in the cen-
tral core region and within the fluctuating N- and C-terminal
regions. The average structure is stabilized in part by clus-
tering of nonpolar hydrophobic side chains and by the
formation of hydrogen bonds.
FIGURE 10 Averaged cross correlation of cartesian coordinate fluctua-
tions in the residues of the WT and E22Q mutant peptides. Regions of red
indicate strong correlation, and regions of blue indicate anticorrelation.
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The frequency of observed hydrogen bonds is shown in
Fig. 9 for both the WT and mutant E22Q peptides. The
hydrogen bonds that occur with greatest frequency are la-
beled. Below each histogram is shown a summary of the
prominent hydrogen bonds. There are several crucial differ-
ences and similarities in the hydrogen bonding patterns of
the WT and E22Q mutant peptides.
The most striking difference between the hydrogen bond-
ing patterns in the WT and E22Q mutant peptides is the
connectivity between the LVFFA and VGSN regions in the
WT peptide and the disruption of those hydrogen bonds in
the E22Q mutant peptide. The E22Q point mutation is
found at the interface between those two regions and it is
sensible to assume that the larger structural fluctuations
found at residue 22 in the E22Q mutant peptide (see above)
are a result of the reduced stability of that region, resulting
from the disruption of spanning hydrogen bonds between
the residues of the LVFFA cluster and the VGSN turn
regions. This is in agreement with experimental NMR
amide hydrogen exchange-rate data, indicating that the av-
erage exchange lifetimes of residues 16–27, excluding V18
and V24, were reduced in the A(12–28)E22Q mutant
peptide relative to the wild type peptide (Zhang, 1999;
Zhang et al., 1998). However, it should be noted that, in
both trajectories, there are significant fluctuations, and none
of the hydrogen bonds in either peptide are truly robust. The
hydrogen bonds that do form tend to be formed intermit-
tently.
The L17–F19 hydrogen bond is observed to be common
to both the WT and E22Q mutant peptides. A second
notable similarity is the apparent special role played by the
N27 residue, which is a highly connected residue in both the
WT and E22Q mutant dynamics. The statistics for each
peptide show four different hydrogen-bond connections in-
volving the N27 sidechain.
A significant difference in the observed hydrogen bond-
ing patterns is that the N27 residue participates in two
common hydrogen bonds between residues of the LVFFA
region in the WT. However, in the E22Q mutant trajecto-
ries, N27 is connected by hydrogen bonds only to local turn
residues or flanking residues in the C-terminal region.
Propensity for secondary structure fluctuations
It has been proposed that the difference in activity observed
for the WT and E22Q mutant peptides can be attributed to
a larger propensity for the formation of  structure in the
monomeric E22Q mutant peptide in solution, relative to the
WT peptide. To test this hypothesis, we have analyzed the
cross correlation of residue fluctuations in the simulated
peptide dynamics.
The computed cross correlation matrices are depicted in
Fig. 10. A number of dominant features are apparent. There
is a strong correlation of fluctuations in the residues of the
peptide’s core, including the LVFFA hydrophobic cluster
FIGURE 11 The atomic solvent-exposed surface area contributed by the
central hydrophobic cluster LVFFA (top) and the total peptide (bottom)
averaged over the simulations of the WT and E22Q mutant peptides.
FIGURE 12 The time-averaged fin order parameters for residues of the
WT and E22Q mutant peptides. The separate averages over the atoms
composing the side chains and backbone are also shown.
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and VGSN turn regions. In the WT peptide, there is a large
block of high correlation through the LVFFAEDVGSN
(17–27) region of the peptide. In the E22Q mutant peptide,
the correlation is noticeably weaker, in agreement with the
observation that the hydrogen-bonding contacts between the
LVFFA and VGSN regions are disrupted.
In both the WT and E22Q mutant data, there are shadows
of the diagonal signature of antiparallel -strand. This in-
dicates the presence of correlated motion consistent with the
formation of -structure but in the absence of the formal
hydrogen-bonding pattern of true -sheet or strand (see
above).
Peptide hydration
In the WT peptide, the E22 residue is negatively charged at
neutral pH, whereas, in the E22Q mutant peptide, the Q22
residue is electrically neutral but polar. It is expected, there-
fore, that the difference could effect the peptide’s activity in
at least two ways. First, the desolvation step, which may
occur at residue 22 in the aggregation of the peptide, could
FIGURE 13 The average binding energy Eb for proximal water molecules, in the LVFFA region and in the VGSN region, is decomposed in the two
contributions Ew (top) and Ep (bottom) over the simulation runs. The energy distributions corresponding to the E22Q mutant peptide are represented in gray,
those of the WT in black.
FIGURE 14 The average binding energy Eb for proximal water mole-
cules around residue 22 is decomposed in the two contributions Ew (top)
and Ep (bottom) over the simulation runs. The energy distributions corre-
sponding to the E22Q mutant peptide are represented in gray, those of the
WT in black.
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be significantly different in the WT or E22Q mutant pep-
tide. Furthermore, the charged E22 residue in the WT pep-
tide would, presumably, become protonated or chelated
with a cation if buried in an amyloid peptide aggregate.
E22Q structure is more solvent exposed than WT peptide
The distributions of total solvent-exposed peptide surface
area and the solvent-exposed surface area contributed by the
hydrophobic cluster of residues LVFFA (17–21) are dis-
played in Fig. 11. The E22Q mutant peptide shows a sig-
nificantly larger absolute measure of solvent-exposed sur-
face area contributed by the LVFFA cluster and over the full
peptide.
The larger solvent-exposed surface observed for the
E22Q mutant peptide (on average more than 100 Å2) is
consistent with the larger observed average radius of gyra-
tion of the E22Q mutant peptide relative to the WT peptide
(on average 0.5 Å).
E22Q mutation leads to change in hydration of
hydrophobic patch
We have examined the nature of the orientational order of
the water in the first solvation shells of the WT and E22Q
mutant peptides using the clathrate/inverted order parameter
analysis developed by Cheng and Rossky (1999). The re-
sults for the averaged order parameter are plotted in Fig. 12.
The principal result of the mutation, from the polar Q22
residue in the Dutch mutant peptide to the charged E22
residue in the WT peptide, is the alteration of the local
inverted water structure in the first solvation shell of residue
22. In both peptides, the LVFFA region is characterized by
an fin order parameter consistent with a somewhat clathrate-
like solvation structure.
The result of the analysis of the energy of the water
molecules in the first hydration shell of the LVFFA and
VGSN regions is presented in Fig. 13. The binding energy,
Eb, has been decomposed in the two contributions—the
interaction energy of the water in the solvation shell with all
the other water molecules in the system, Ew, and with the
peptide, Ep. The distributions of Ew and Ep have been fit to
gaussian distributions. The distributions of Ew show a dif-
ferent result for the LVFFA and the VGSN regions. The
gaussian distribution for Ew of the LVFFA region of the
E22Q mutant is shifted toward lower mean energy than that
of the WT. The gaussian fit for Ew in the VGSN region does
not differ significantly between the WT and E22Q peptides.
A more negative value of Ew in the LVFFA region of the
E22Q mutant relative to the WT peptide indicates that the
structure of the water around this region is energetically
more clathrate-like in the Dutch mutant than in the WT.
The distributions of Ep in the VGSN region are similar
for the WT and the E22Q mutant peptides. In the LVFFA
region, however, the distribution of Ep energies for the
E22Q mutant is characterized by higher energies relative to
the same interactions in the WT peptide. This result dem-
onstrates that the interaction between the water molecules in
the first solvation shell of the LVFFA region of the peptide
is less attractive in the Dutch mutant than in the WT.
The distributions of Ew and Ep for residue 22 are pre-
sented in Fig. 14. The distribution of the binding energy
shows that the E22Q mutant peptide is characterized by
more (favorable) negative values of Ew and less (favorable)
negative values of Ep than in the WT peptide. The results
can be explained by noting that the charged residue in the
WT is expected to have a more attractive interaction with
the solvent in an inverted structure. The mutation at residue
22 leads to a different structure and energy of the water
around this residue, but also influences the fluctuations in
the peptide and the structure and energetics of the first
hydration shell about the LVFFA region.
When the monomeric peptide encounters a pre-existing
fibril, there will be a desolvation step associated with the
burial of the monomeric peptide’s hydrophobic surface. In
the case of the E22Q mutant, the desolvation step will be
associated with an increase in solvent entropy and relatively
little change in the solvent enthalpy. However, for the
desolvation of the WT peptide, there will be a significant
enthalpic cost associated with the desolvation of the charged
E22 residue. Overall, the association of the monomeric
peptide with the fibril interface is expected to be both
enthalpically and entropically more favorable in the case of
the E22Q mutant.
In a previous study (Esler et al., 2000a) it was suggested
that different entropies of activation, S‡, characterize the
aggregation process of the WT and E22Q mutant A-
peptides. That result was interpreted in terms of differing
flexibility of the two peptides. In the light of our study, the
different entropy of activation may be interpreted in terms
of the solvation/desolvation process in the aggregation of
the peptide. However, it is difficult to predict the exact
effect that the changes in hydration shell structure have on
the activation entropies of the peptides. The E22Q mutant
peptide is characterized by a more clathrate-like structure of
the first solvation shell, relative to the WT peptide, with a
lower associated entropy. The difference between the rela-
tive conformational entropies of the peptides in solution is
not so easily predicted, nor is the entropy difference of the
transition states of the peptide–water system along the ag-
gregation pathway. From our simulations of the peptides in
aqueous solution, we cannot clearly predict either the value
or the sign of the difference between the entropy of activa-
tion of the WT and E22Q mutant peptides for the aggrega-
tion process, S‡ 	 SWT‡  SE22Q‡ . Such an interpreta-
tion must await the results of a detailed analysis of proposed
pathways for peptide aggregation currently under study
(Massi and Straub, 2001).
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SUMMARY AND CONCLUSIONS
The results of our multiple-nanosecond time scale molecu-
lar dynamics trajectories of the solvated A peptide conge-
ner in its WT and E22Q mutant forms support a number of
conclusions related to the structure, fluctuations, dynamics,
and hydration of the peptide.
1. The E22Q mutant and WT peptide are both stable in cc
conformations consistent with the WT structure of Lee
and coworkers (Zhang et al., 2000). The structure of the
central hydrophobic core is preserved throughout the
entire simulation for both systems.
2. In solution, the E22Q peptide is more flexible than the
WT, supporting an early hypothesis that the equilibrium
structural fluctuations of the E22Q mutant peptide were
larger than those of the WT peptide (Zhang et al., 1998).
The E22Q mutant peptide presents a wider distribution
of the end-to-end distances than does the WT peptide.
The fluctuations of the 	 and  angles of the residues in
the 22–27 region are larger in the E22Q mutant than in
the WT peptide. The RMS fluctuations of atoms of the
E22Q peptide are larger than those of the WT for all the
aminoacids in the 17–26 region.
3. The values of the S2 order parameter are consistently
smaller in the Dutch mutant than in the WT peptide in
the region between residue 21 and residue 26, which
indicates that the motion of the NH amide bond is less
restricted in the Dutch mutant than in the WT peptide.
The absence of hydrogen bonds between the LVFFA and
the VGSN regions in the E22Q mutant, which are
present in the WT peptide, is correlated with the higher
degree of flexibility of the structure of the mutant peptide
around residue 22.
4. A comparison of the solvent-exposed surface area of the
two peptides shows that the E22Q mutant peptide has a
greater hydrophobic surface area exposed to the solvent.
The mutant peptide also presents a larger radius of gy-
ration than does the WT peptide. The local E22Q muta-
tion leads to a local perturbation of the peptide hydration
and the structure of the first solvation layer in the region
of residue 22.
5. The water–water interaction energy for the waters of the
first solvation shell of the LVFFA hydrophobic patch
residues is significantly more favorable (more negative)
in the mutant peptide. This is correlated with a less
favorable (less negative) water–peptide interaction. Both
observations are consistent with the formation of a more
hydrophobic solvation shell over the hydrophobic patch
of the E22Q mutant peptide. This difference should
result in a small energetic cost of desolvation of the
Dutch mutant peptide in the aggregation process relative
to the WT peptide. These observations suggest that the
Dutch mutant peptide may have a lower barrier and
larger enthalpic driving force to desolvation and aggre-
gation than does the WT peptide, in agreement with the
noted increased activity of the Dutch mutant peptide.
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